The Gordon Research Seminar on Bioanalytical Sensors is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this meeting is on new bioanalytical sensors and solutions that provide highly specific and quantitative molecular data of biological systems. Specific topics will include micro- and nanofluidics, nanomaterials, in vitro and in vivo imaging, instrumental techniques, and real world detection/diagnosis.
This GRS was held in conjunction with the "Bioanalytical Sensors" Gordon Research Conference (GRC)
. Refer to the associated GRC program page
for more information.
Final Meeting Program
|2:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Session: Micro- and Nanofluidic Technologies for Addressing Biochemical Measurements|
|Discussion Leaders: Josephine Cunningham (Paratus Diagnostics, USA) and Quinn Best (Louisiana State University, USA)|
|3:45 pm - 4:15 pm||Michael Ramsey (The University of North Carolina at Chapel Hill, USA)|
"Micro- and Nanofluidic Technologies for Addressing Biochemical Measurements"
|4:15 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session|
|7:30 pm - 9:30 pm||Nanotechnology: From Materials to Sensing|
|Discussion Leaders: Quinn Best (Louisiana State University, USA) and Josephine Cunningham (Paratus Diagnostics, USA)|
|7:30 pm - 7:50 pm||Philippa Reutersward (KTH Royal Institute of Technology, Sweden)|
Detection of Inflammatory Markers for Point-of-Care Testing Using Vertical
|7:50 pm - 8:00 pm||Discussion|
|8:00 pm - 8:20 pm||Yao Du (University of Cambridge, United Kingdom)|
"Particle Modified Surface Plasmon Resonance (SPR) Sensor"
|8:20 pm - 8:30 pm||Discussion|
|8:30 pm - 8:50 pm||Giorgia Giovannini (University of Kent, United Kingdom)|
"Developing Silica Nanoparticles for Bacteria Detection"
|8:50 pm - 9:00 pm||Discussion|
|9:00 pm - 9:20 pm||Paul DeGregory (University of Texas at Austin, USA)|
Metalloimmunoassay for TFF3 in Urine Using a Paper Analytical Device"
|9:20 pm - 9:30 pm||Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 11:00 am||In Vitro and In Vivo Sensing and Imaging|
|Discussion Leader: Andreas Weltin (IMTEK, University of Freiburg, Germany)|
|9:00 am - 9:20 am||Netz Arroyo (University of California Santa Barbara, USA)|
"Continuous, Real-Time Molecular Monitoring Directly In Vivo"
|9:20 am - 9:30 am||Discussion|
|9:30 am - 9:50 am||Bijeta Prasai (Louisiana State University, USA)|
"Fluorescent Probe Activation and hNQO1 Activity in Solid Tumor Mimics"
|9:50 am - 10:00 am||Discussion|
|10:00 am - 10:20 am||Robert Soto (University of North Carolina at Chapel Hill, USA)|
Tissue Biocompatibility of Implanted Electrochemical Glucose Biosensors"
|10:20 am - 10:30 am||Discussion|
|10:30 am - 10:50 am||Ryo Nishihara (Keio University, Japan)|
"Bioluminescence Imaging of Hydrogen Sulfide in Living Cells"
|10:50 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Microfluidics: Techniques in Cell Detection and Discrimation|
|Discussion Leader: Kumuditha Weerakoon-Ratnayake (University of North Carolina at Chapel Hill, USA)|
|1:30 pm - 1:50 pm||Peter Aldridge (University of Toronto, Canada)|
"Continuous Flow Purification and Phenotypic Profiling of Rare Cell Subpopulations Using Microfluidics"
|1:50 pm - 2:00 pm||Discussion|
|2:00 pm - 2:20 pm||Syrena Fernandes (Tufts University, USA)|
of a Paper-Based Microfluidic Device for the Determination of the Hematocrit"
|2:20 pm - 2:30 pm||Discussion|
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill in GRS Evaluation Forms|
|3:00 pm||Seminar Concludes|
Funding for this conference was made possible (in part) by 1R13EB022399-01 from the National Institute of Biomedical Imaging and Bioengineering. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.